The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Facial Skin Shield Broad Spectrum SPF50 Plus
avobenzone, ensulizole, homosalate, octisalate, and octocrylene · AVOBENZONE .0284 g/mL; ENSULIZOLE .03 g/mL; HOMOSALATE .073 g/mL; OCTISALATE .05 g/mL; OCTOCRYLENE .0989 g/mL · Cream · Topical · AHAVA - Dead Sea Laboratories Ltd
NDC 60289-0302-24 · 1 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of avobenzone, ensulizole, homosalate, octisalate, and octocrylene (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AHAVA - Dead Sea Laboratories Ltd | AVOBENZONE .0284 g/mL; ENSULIZOLE .03 g/mL; HOMOSALATE .073 g/mL; OCTISALATE .05 g/mL; OCTOCRYLENE .0989 g/mL | Jul 15, 2026 | Sep 2, 2026 |
| AHAVA - Dead Sea Laboratories Ltd | AVOBENZONE 29.982 mg/mL; ENSULIZOLE 20 mg/mL; HOMOSALATE 70 mg/mL; OCTISALATE 50 mg/mL; OCTOCRYLENE 8.7 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Facial Skin Shield Broad Spectrum SPF50 Plus — NDC 60289-0302-24," retrieved September 3, 2026, https://drugdashboards.com/drug/60289030224.
Free to cite with attribution — see how the data is put together.